WELL Health is expected to report C$0.06 in earnings per share (EPS) on revenue of C$407.37 million. In its last four comparable quarters, the company beat EPS estimates twice and missed twice.
WELL Health Technologies Corp. is scheduled to report results after market close on November 9, 2026, for the quarter ended September 30. Analysts expect EPS of C$0.06, with estimates ranging from C$0.03 to C$0.11, and revenue of C$407.37 million.
Recent earnings trend
WELL Health Technologies Corp
WELL.TO
WELL.TO
WELL Health Technologies Corp
WealthAwesomeMarket cap
$1.06B
P/E
207.5x
52W high
$5.19
52W low
$3.58
1W change
+0.97%
Beta
1.24
Analyst Price Targets
Based on analyst covering WELL · as of Oct 5, 2026
Wall Street analysts forecast WELL stock price to rise 73.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.21
+73.8% Upside
Previously C$7.30 on Oct 2, 2026
Current Price
C$4.15
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on WELL's historical volatility
30-Day Vol
30.7%
Annualized
90-Day Vol
32.3%
Annualized
Trend (90d)
-5.0%
Annualized drift
90d Mean
C$4.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$4.13 | C$3.71 – C$4.59 |
| 60 trading days | C$4.10 | C$3.53 – C$4.76 |
| 90 trading days | C$4.08 | C$3.39 – C$4.90 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 8 analyst(s) cover this name; upcoming EPS consensus is available.
Beat estimates in 2 of the last 4 comparable quarter(s).
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-09-30 | 2026-11-09 | — | 0.0600 | — |
| 2026-06-30 | 2026-08-06 | 0.0400 | 0.0600 | -33.3% |
| 2026-03-31 | 2026-05-13 | -0.0486 | 0.0600 | -181.0% |
| 2025-12-31 | 2026-03-19 | 0.2000 | 0.1100 | +81.8% |
| 2025-09-30 | 2025-11-06 | 0.1600 | 0.1000 | +60.0% |
| 2025-06-30 | 2025-08-14 | 0.1000 | 0.0900 | +11.1% |
The key question is whether revenue growth will lead to stronger earnings. Analysts expect revenue to rise 11.7% year over year, while EPS is forecast to fall 61.1% from C$0.16 a year ago. Follow WELL.TO on the WELL Health stock page.
Investor takeaway: This earnings report will show whether WELL can keep growing revenue while improving its thin profit margins. Analysts expect C$0.06 in EPS and C$407.37 million in revenue. The EPS estimate has edged down from C$0.07 over the past 30 days, and the company has beaten and missed estimates twice each in its last four comparable quarters. For Canadian investors, the EPS result matters, but revenue, margins and management’s outlook will help show whether growth is turning into earnings.
C$0.06 EPS consensus
Analysts expect EPS of C$0.06, down 61.1% from C$0.16 in the same quarter last year. Revenue is forecast at C$407.37 million, up 11.7% year over year. With revenue expected to grow while EPS falls, investors will be watching margins and the quality of earnings.
Bull case
Analysts expect revenue to grow 11.7% year over year to C$407.37 million. In its August 6 release, WELL reported Q2 revenue of C$400 million, said Canadian Patient Services revenue grew 32%, and raised its 2026 annual guidance. Those results give investors a recent benchmark for the upcoming report. Revenue near or above expectations, alongside stable or improving profitability, would support the view that growth is translating into stronger financial results.
Bear case
Analysts expect EPS of C$0.06, well below the C$0.16 reported a year earlier. WELL’s recent record is mixed: EPS missed estimates in its two most recent reported quarters and beat them in the two before that. The consensus estimate has also fallen from C$0.07 to C$0.06 over the past month. With trailing EPS of C$0.02 and a reported profit margin of 0.25%, investors may question whether revenue growth is leading to enough earnings improvement.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
